ArticleBacteriophage
Experimental evolution and bacterial resistance: (co)evolutionary costs and trade-offs as opportunities in phage therapy research.
Article in Bacteriophage. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- The Zoetrope effect in phage evolution.Frontiers in microbiology · 2026Article
- Review
- Bacteriophages-Dangerous Viruses Acting Incognito or Underestimated Saviors in the Fight against Bacteria?International journal of molecular sciences · 2024Review
- Phage-driven coevolution reveals trade-off between antibiotic and phage resistance inISME communications · 2024Article
- Targeted enhancement of bacteriophage activity against antibiotic-resistantFrontiers in microbiology · 2024Article
- Phage-resistant mutations impact bacteria susceptibility to future phage infections and antibiotic response.Ecology and evolution · 2023Article
- Article
- A Phage Foundry Framework to Systematically Develop Viral Countermeasures to Combat Antibiotic-Resistant Bacterial Pathogens.iScience · 2022Review
- Parallel evolution ofeLife · 2022Article
- Bacteriophages in the Control ofAntibiotics (Basel, Switzerland) · 2022Review
- Application of Bacteriophages on Shiga Toxin-ProducingAntibiotics (Basel, Switzerland) · 2021Article
- Article
- Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance.Proceedings of the National Academy of Sciences of the United States of America · 2020Article
- Phages for Biofilm Removal.Antibiotics (Basel, Switzerland) · 2020Review
- Biological challenges of phage therapy and proposed solutions: a literature review.Expert review of anti-infective therapy · 2019Review
- Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.Microbiology and molecular biology reviews : MMBR · 2019Review
- Resistance Evolution against Phage Combinations Depends on the Timing and Order of Exposure.mBio · 2019Article
- Directed Evolution of a Mycobacteriophage.Antibiotics (Basel, Switzerland) · 2019Article
- Gut Bacteriophage: Current Understanding and Challenges.Frontiers in endocrinology · 2019Review
- Rapid evolution of generalized resistance mechanisms can constrain the efficacy of phage-antibiotic treatments.Evolutionary applications · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antagonistic coevolution between bacteria and phages (reciprocal selection for resistance and infectivity) has been demonstrated in a wide range of natural ecosystems, as well as experimental populations of microbes, yet exploiting knowledge of coevolution for the prophylactic and therapeutic use of phages is under-explored. In this addendum to our recent paper we discuss how real-time coevolution studies using experimental populations of bacteria and phages can provide novel insight into the changes in bacterial phenotypes that result from resistance evolution against coevolving phages, and how this may ultimately improve our understanding of phage therapy and ability to design effective treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.